|
gptkbp:instanceOf
|
gptkb:biotechnology
|
|
gptkbp:CEO
|
gptkb:Igor_Khandros
|
|
gptkbp:country
|
gptkb:United_States
|
|
gptkbp:focusesOn
|
oncology
personalized medicine
immuno-oncology
RNA therapeutics
|
|
gptkbp:foundedYear
|
2018
|
|
gptkbp:founder
|
gptkb:David_Milne
gptkb:Geoffrey_von_Maltzahn
gptkb:Igor_Khandros
|
|
gptkbp:headquartersLocation
|
gptkb:Emeryville,_California,_United_States
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Nutcracker Therapeutics
|
|
gptkbp:industry
|
gptkb:biotechnology
|
|
gptkbp:notableInvestment
|
gptkb:Arch_Venture_Partners
gptkb:Alexandria_Venture_Investments
gptkb:Casdin_Capital
gptkb:DCVC
gptkb:Wellington_Management
gptkb:Bluebird_Ventures
gptkb:Boxer_Capital
gptkb:Cormorant_Asset_Management
gptkb:Janus_Henderson_Investors
gptkb:Lifeforce_Capital
gptkb:Mission_BioCapital
gptkb:Surveyor_Capital
gptkb:Woodline_Partners
|
|
gptkbp:notableProduct
|
gptkb:NTC-200
gptkb:NTC-300
gptkb:NTC-400
|
|
gptkbp:productType
|
RNA-based medicines
|
|
gptkbp:publiclyTraded
|
yes
|
|
gptkbp:stockExchange
|
gptkb:NASDAQ
|
|
gptkbp:stockSymbol
|
gptkb:NTCR
|
|
gptkbp:technology
|
automation
microfluidics
digital biomanufacturing
end-to-end RNA manufacturing platform
mRNA platform
|
|
gptkbp:website
|
https://www.nutcrackertherapeutics.com/
|
|
gptkbp:bfsParent
|
gptkb:Samir_Kaul
|
|
gptkbp:bfsLayer
|
6
|